Cargando…
Hepatitis C, mental health and equity of access to antiviral therapy: a systematic narrative review
INTRODUCTION: Access to hepatitis C (hereafter HCV) antiviral therapy has commonly excluded populations with mental health and substance use disorders because they were considered as having contraindications to treatment, particularly due to the neuropsychiatric effects of interferon that can occur...
Autores principales: | Hepworth, Julie, Bain, Tanya, van Driel, Mieke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3842744/ https://www.ncbi.nlm.nih.gov/pubmed/24245959 http://dx.doi.org/10.1186/1475-9276-12-92 |
Ejemplares similares
-
The cost of successful antiviral therapy in hepatitis C patients: a comparison of IFN-free versus IFN-based regimens at an individual patient level in Australia
por: Lee, Allister Sebastian, et al.
Publicado: (2017) -
Accessibility to Oral Antiviral Therapy for Patients with Chronic Hepatitis C in the United States
por: Saab, Sammy, et al.
Publicado: (2016) -
Impact of an Open Access Nationwide Treatment Model on Hepatitis C Virus Antiviral Drug Resistance
por: Douglas, Mark W., et al.
Publicado: (2020) -
Access to antiviral therapy for chronic hepatitis B during COVID-19
por: Bertolli¹, Marilia Rocha, et al.
Publicado: (2022) -
Accessing hepatitis C direct acting antivirals among people living with hepatitis C: a qualitative study
por: Antoniou, Tony, et al.
Publicado: (2023)